Resultados de procura - Eric Padron
- Mostrando 1 - 20 Resultados de 58
- Go to Next Page
-
1
-
2
-
3
-
4
Key Lessons Learned from Moffitt’s Molecular Tumor Board: The Clinical Genomics Action Committee Experience por Todd C. Knepper, Gillian C. Bell, J. Kevin Hicks, Eric Padron, Jamie K. Teer, Teresa T. Vo, Nancy Gillis, Neil Mason, R COOPERDEHOFF, Christine M. Walko
Publicado 2017Artigo -
5
Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia por K. L. McGraw, Johnny Nguyen, Rami S. Komrokji, D. Sallman, Najla H. Al Ali, Eric Padron, J. E. Lancet, Lynn C. Moscinski, Alan F. List, L. Zhang
Publicado 2016Carta -
6
Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis por Chetasi Talati, Ling Zhang, Ghada Shaheen, Andrew Kuykendall, Markus Ball, Qing Zhang, Jeffrey E. Lancet, Kenneth S. Zuckerman, Alan F. List, Rami S. Komrokji, Lynn C. Moscinski, Eric Padron
Publicado 2017Carta -
7
Prognostic significance of serial molecular annotation in myelodysplastic syndromes (MDS) and secondary acute myeloid leukemia (sAML) por Seongseok Yun, Susan Geyer, Rami S. Komrokji, Najla H. Al Ali, Jinming Song, Mohammad Hussaini, Kendra Sweet, Jeffrey E. Lancet, Alan F. List, Eric Padron, David A. Sallman
Publicado 2020Artigo -
8
-
9
Structure of Adeno-Associated Virus Serotype 8, a Gene Therapy Vector por Hyun-Joo Nam, Michael Douglas Lane, Eric Padron, Brittney L. Gurda, Robert McKenna, Erik Kohlbrenner, George Aslanidi, Barry J. Byrne, Nicholas Muzyczka, Sergei Zolotukhin, Mavis Agbandje‐McKenna
Publicado 2007Artigo -
10
Validation of the revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes por Asmita Mishra, Maria Corrales‐Yepez, Najla Al Ali, Mohamed A. Kharfan‐Dabaja, Eric Padron, Ling Zhang, Pearlie K. Epling‐Burnette, Javier Pinilla‐Ibarz, Jeffrey E. Lancet, Alan F. List, Rami S. Komrokji
Publicado 2013Artigo -
11
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome por Mrinal M. Patnaik, Emnet A Wassie, Eric Padron, Francesco Onida, Raphaël Itzykson, Terra L. Lasho, Olivier Kosmider, Christy Finke, Curtis A. Hanson, Rhett P. Ketterling, Rami S. Komrokji, Ayalew Tefferi, Éric Solary
Publicado 2015Artigo -
12
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes por Anthony M. Hunter, Rami S. Komrokji, Seongseok Yun, Najla Al Ali, Onyee Chan, Jinming Song, Mohammad Hussaini, Chetasi Talati, Kendra Sweet, Jeffrey E. Lancet, Eric Padron, Alan F. List, David A. Sallman
Publicado 2021Artigo -
13
Patterns of lower risk myelodysplastic syndrome progression: factors predicting progression to high-risk myelodysplastic syndrome and acute myeloid leukemia por Akriti G Jain, Somedeb Ball, Luis E. Aguirre, Najla Al Ali, David Kaldas, Sara Tinsley, Andrew Kuykendall, Onyee Chan, Kendra Sweet, Jeffrey E. Lancet, Eric Padron, David A. Sallman, Rami S. Komrokji
Publicado 2024Artigo -
14
Hypoalbuminemia is an independent prognostic factor for overall survival in myelodysplastic syndromes por Rami S. Komrokji, Maria Corrales‐Yepez, Mohamed A. Kharfan‐Dabaja, Najla H. Al Ali, Eric Padron, Dana E. Rollison, Javier Pinilla‐Ibarz, Ling Zhang, Pearlie K. Epling‐Burnette, Jeffrey E. Lancet, Alan F. List
Publicado 2012Artigo -
15
Autoimmune diseases and myelodysplastic syndromes por Rami S. Komrokji, Austin Kulasekararaj, Najla H. Al Ali, Shahram Kordasti, Emily Bart‐Smith, Benjamin M. Craig, Eric Padron, Ling Zhang, Jeffrey E. Lancet, Javier Pinilla‐Ibarz, Alan F. List, Ghulam J. Mufti, Pearlie K. Epling‐Burnette
Publicado 2016Artigo -
16
Diagnosis and Treatment of Chronic Myelomonocytic Leukemias in Adults por Raphaël Itzykson, Pierre Fenaux, David Bowen, Nicholas C.P. Cross, Jorge E. Cortés, Théo de Witte, Ulrich Germing, Francesco Onida, Eric Padron, Uwe Platzbecker, Valeria Santini, Guillermo Sanz, Éric Solary, Arjan van de Loosdrecht, Luca Malcovati
Publicado 2018Revisão -
17
Germ line tissues for optimal detection of somatic variants in myelodysplastic syndromes por Eric Padron, Markus Ball, Jamie K. Teer, Jeffrey S. Painter, Sean J. Yoder, Chaomei Zhang, Ling Zhang, Lynn C. Moscinski, Dana E. Rollison, Steven D. Gore, Rafael Bejar, Matthew J. Walter, Mikkael A. Sekeres, Rami S. Komrokji, Pearlie K. Epling‐Burnette
Publicado 2018Carta -
18
Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasm por Nadia Gharaee, Joanna Wegrzyn-Woltosz, Jihong Jiang, Vijay Suresh Akhade, Joshua Bridgers, Ryan J. Stubbins, Devendra Hiwase, Monika Kutyna, Onyee Chan, Rami S. Komrokji, Eric Padron, Yu Deng, Gary W. Cole, Patricia Umlandt, Megan Fuller, A. H. Kim, Aly Karsan
Publicado 2025Artigo -
19
GM-CSF–dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia por Eric Padron, Jeffrey S. Painter, Sateesh Kunigal, Adam W. Mailloux, Kathy L. McGraw, Jessica M. McDaniel, Eun Hee Kim, Christopher Bebbington, Mark Baer, Geoffrey Yarranton, Jeffrey E. Lancet, Rami S. Komrokji, Omar Abdel‐Wahab, Alan F. List, Pearlie K. Epling‐Burnette
Publicado 2013Artigo -
20
Managing Clonal Hematopoiesis in Patients With Solid Tumors por Kelly L. Bolton, Nancy Gillis, Catherine C. Coombs, Koichi Takahashi, Ahmet Zehir, Rafael Bejar, Guillermo Garcia‐Manero, P. Andrew Futreal, Brian C. Jensen, Luis A. Díaz, Dipti Gupta, Simon Mantha, Virginia M. Klimek, Elli Papaemmanuil, Ross L. Levine, Eric Padron
Publicado 2018Artigo
Ferramentas de procura:
Materias Relacionadas
Medicine
Internal medicine
Biology
Bone marrow
Myelodysplastic syndromes
Oncology
Gene
Genetics
Cancer research
Immunology
Myeloid
Myeloid leukemia
Chronic myelomonocytic leukemia
Cancer
DNA methylation
Gastroenterology
Gene expression
International Prognostic Scoring System
Biochemistry
Mutation
Azacitidine
Haematopoiesis
Leukemia
Stem cell
Cell biology
Cohort
Computational biology
Decitabine
Pathology
Disease